Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
31 Dec 2013 FDA Authorised First Next-Generation Sequencer Personalised medicine
30 Dec 2013 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Cabozantinib for the Treatment of Medullary Thyroid Cancer Endocrine cancers - Anticancer agents & Biologic therapy
19 Dec 2013 Systems medicine paves the way for improved treatment for AML patients Personalised medicine - Translational research - Haematologic malignancies
18 Dec 2013 Misunderstanding of Palliative Care Palliative and supportive care
17 Dec 2013 A Study of Anastrozole in Breast Cancer Chemoprevention Breast cancer - Cancer prevention
16 Dec 2013 Obinutuzumab/Chlorambucil in the First-Line Treatment of Older CLL Patients Cancer in Special Situations - Haematologic malignancies - Anticancer agents & Biologic therapy
12 Dec 2013 Phase III Study of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukaemia Haematologic malignancies - Anticancer agents & Biologic therapy
11 Dec 2013 CALR Mutations in Myeloproliferative Neoplasms Translational research - Haematologic malignancies
09 Dec 2013 Learning From the FDA Breakthrough Therapies Pathway Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
05 Dec 2013 APO-SYS: How Modulation of Apoptosis Can be Used in the Treatment of Cancer and AIDS Translational research
04 Dec 2013 Onartuzumab in Combination with Erlotinib in Patients with Advanced NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 Dec 2013 Exome Sequencing Identifies Frequent Inactivating Mutations in Intrahepatic Cholangiocarcinomas Translational research - Gastrointestinal cancers
29 Nov 2013 European Medicines Agency Recommends Changes in Use of Ponatinib in Order to Minimise Risk of Thrombosis Anticancer agents & Biologic therapy
27 Nov 2013 European Medicines Agency Issues Positive Recommendation on Generic Zoledronic Acid Palliative and supportive care
26 Nov 2013 European Medicines Agency Recommends Extension of Indications for Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) Gastrointestinal cancers - Anticancer agents & Biologic therapy